Impaired regulation of 3-hydroxy-3-methylglutaryl-coenzyme a reductase degradation in lovastatin-resistant cells

26Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

L-90 cells were selected to grow in the presence of serum lipoproteins and 90 μM lovastatin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase (IMGR). L-90 cells massively accumulate IMGR, a result of > 10-fold amplification of the gene and 40-fold rise in mRNA, and also overexpress other enzymes of the mevalonate pathway. Western blot and promoter-luciferase analyses indicate that transcriptional regulation of sterol-responsive genes by 25-hydroxycholesterol or mevalonate is normal. Yet, none of these genes is regulated by lipoproteins, a result of severe impairment in the low density lipoprotein receptor pathway. Moreover, L-90 cells do not accelerate the degradation of HMGR or transfected HMGal chimera in response to 25- hydroxycholesterol or mevalonate. This aberrant phenotype persists when cells are grown without lovastatin for up to 37 days. The inability to regulate HMGR degradation is not due to its overproduction since in LP-90 cells, which were selected for lovastatin resistance in lipoprotein-deficient serum, HMGR is overexpressed, yet its turnover is regulated normally. Also, the rapid degradation of transfected α subunit of T cell receptor is markedly retarded in L-90 cells. These results show that in addition to gene amplification and overexpression of cholesterogenic enzymes, statin resistance can follow loss of regulated HMGR degradation.

References Powered by Scopus

Regulation of the mevalonate pathway

4914Citations
N/AReaders
Get full text

A receptor-mediated pathway for cholesterol homeostasis

4676Citations
N/AReaders
Get full text

The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor

3217Citations
N/AReaders
Get full text

Cited by Powered by Scopus

HMG-CoA reductase inhibitors and the malignant cell: The statin family of drugs as triggers of tumor-specific apoptosis

531Citations
N/AReaders
Get full text

Progression of coronary artery calcium and risk of first myocardial infarction in patients receiving cholesterol-lowering therapy

284Citations
N/AReaders
Get full text

The ubiquitin-proteasome pathway mediates the regulated degradation of mammalian 3-hydroxy-3-methylglutaryl-coenzyme A reductase

131Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Ravid, T., Avner, R., Polak-Charcon, S., Faust, J. R., & Roitelman, J. (1999). Impaired regulation of 3-hydroxy-3-methylglutaryl-coenzyme a reductase degradation in lovastatin-resistant cells. Journal of Biological Chemistry, 274(41), 29341–29351. https://doi.org/10.1074/jbc.274.41.29341

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 6

46%

Professor / Associate Prof. 4

31%

Researcher 2

15%

Lecturer / Post doc 1

8%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 7

58%

Biochemistry, Genetics and Molecular Bi... 4

33%

Environmental Science 1

8%

Save time finding and organizing research with Mendeley

Sign up for free